7532:TSEPan Pacific International Holdings Corporation Analysis
Data as of 2026-06-22 - not real-time
¥810.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Pan Pacific International Holdings is trading at ¥810, well below its 20‑day (¥835.7), 50‑day (¥880.4) and 200‑day (¥950.1) moving averages, signaling a bearish technical backdrop. However, the RSI of 36.99 suggests the stock is approaching oversold territory, and the MACD histogram has turned positive, indicating a potential short‑term rebound toward the immediate resistance at ¥907.4. Volatility remains elevated at 34% over the past 30 days, and trading volume is on a downtrend, which adds uncertainty to price moves. On the fundamentals side, revenue grew 10.2% YoY and forward earnings are projected to surge, reflected in a forward P/E of 4.57 versus a trailing P/E of 24.24. The company carries a high debt‑to‑equity ratio of 55.8 and a negative beta of –0.36, underscoring both leverage risk and defensive market behavior. Despite these concerns, the dividend yield of 1.04% with a 24.5% payout ratio appears sustainable given the strong cash flow generation. A discounted cash flow model values the shares at roughly ¥445, implying the current price is significantly above intrinsic estimates, yet analyst consensus targets around ¥1,100, driven by expectations of earnings acceleration. The market sentiment is extremely bullish (Fear & Greed Index 91.46), which may be inflating price expectations. Balancing the technical weakness, high leverage, and optimistic earnings outlook suggests a nuanced outlook: potential upside if earnings materialize, but downside risk if debt pressures persist. Investors should weigh the short‑term bounce potential against longer‑term valuation concerns.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- RSI near oversold levels
- Bullish MACD histogram
- Support zone around ¥795
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Forward earnings surge (forward EPS ¥177.19)
- Forward P/E of 4.57 indicating cheap valuation
- Analyst target price near ¥1,100
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- High debt‑to‑equity ratio (55.8)
- DCF fair value well below current price
- Defensive consumer sector providing stability
Key Metrics & Analysis
Financial Health
Revenue Growth10.20%
P/E Ratio24.2
Debt/Equity55.75
P/B Ratio3.5
Op. Cash Flow¥154.9B
Free Cash Flow¥76.5B
Technical Analysis
TrendBearish
RSI37.0
Support¥794.70
Resistance¥907.40
MA 20¥835.71
MA 50¥880.42
MA 200¥950.09
MACDBullish
VolumeDecreasing
Fear & Greed Index91.46
Valuation
Fair Value¥444.74
Target Price¥1,095.79
Upside/Downside35.28%
GradeOvervalued
TypeGrowth
Dividend Yield1.04%
Risk Assessment
Beta-0.36
Volatility34.37%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.